Inventor · disambiguated record
Ursula Mönning
Also filed as: MOENNING URSULA · MONNING URSULA · Mönning Ursula
19 granted patents·22 pending applications·73 citations·filing 2002–2024
92Inventor score
Top patents by PatentIndex Score
41 records- 0193US11492358B1Macrocyclic indole derivativesBAYER AG·Filed 2021·Granted Nov 8, 2022·3 cites·18 claims
- 0288US12152041B2Macrocyclic fluorine substituted indole derivativesBROAD INST INC·Filed 2022·Granted Nov 26, 2024·1 cites·6 claims
- 0387US11440923B2Substituted macrocyclic indole derivativesBAYER AG·Filed 2018·Granted Sep 13, 2022·3 cites·15 claims
- 0486US11401278B2Macrocyclic indole derivativesBROAD INST INC·Filed 2018·Granted Aug 2, 2022·3 cites·13 claims
- 0585US11286263B2Macrocyclic fluorine substituted indole derivativesBROAD INST INC·Filed 2018·Granted Mar 29, 2022·3 cites·9 claims
- 0684US6849416B2Monoclonal antibodyFiled 2002·Granted Feb 1, 2005·40 cites·27 claims
- 0777US9682974B2Heteroaryl substituted pyrazolesBayer Pharma AG·Filed 2014·Granted Jun 20, 2017·4 cites·8 claims
- 0875US9745285B2Heteroaryl substituted pyrazolesBayer Pharma AG·Filed 2014·Granted Aug 29, 2017·3 cites·5 claims
- 0975US9278925B2Substituted 3-(biphenyl-3-yl)-4-hydroxy-8-methoxy-1-azaspiro[4.5]dec-3-en-2-oneLIU NINGSHU·Filed 2012·Granted Mar 8, 2016·3 cites·8 claims
- 1074US11339157B14H-pyrrolo[3,2-c]pyridin-4-one derivativesBAYER AG·Filed 2018·Granted May 24, 2022·2 cites·19 claims
- 1174US9765058B2Substituted benzylpyrazolesBayer Pharma AG·Filed 2014·Granted Sep 19, 2017·3 cites·14 claims
- 1273US9000026B2Substituted 3-(biphenyl-3-yl)-8,8-difluoro-4-hydroxy-1-azaspiro[4.5]dec-3-en-2-ones for therapyLIU NINGSHU·Filed 2012·Granted Apr 7, 2015·2 cites·7 claims
- 1371US2025136599A14h-pyrrolo[3,2-c]pyridin-4-one compoundsBAYER AG·Filed 2024·Application pending·0 cites
- 1470US8895549B2Aminoalcohol substituted 2,3-dihydroimidazo[1,2-c]quinazoline derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesisSCOTT WILLIAM JOHNSTON·Filed 2011·Granted Nov 25, 2014·2 cites·15 claims
- 1566US10350206B2Benzyl substituted indazoles as BUB1 inhibitorsBayer Pharma AG·Filed 2015·Granted Jul 16, 2019·1 cites·28 claims
- 1661US2016046604A1Heteroaryl substituted indazolesBayer Pharma AG·Filed 2014·Application pending·0 cites
- 1756US2023064983A13-(anilino)-2-[3-(3-alkoxy-pyridin-4-yl]-1,5,6,7-tetrahydro-4h-pyrrolo[3,2-c]pyridin-4-one derivatives as egfr inhibitors for the treatment of cancerBAYER AG·Filed 2022·Application pending·0 cites
- 1854US7196202B21-aryl-2-N-, S- or O-substituted benzimidazole derivatives, their use for the production of pharmaceutical agents as well as pharmaceutical preparations that contain these derivativesSCHERING AG·Filed 2005·Granted Mar 27, 2007·0 cites·14 claims
- 1954US2022298157A14h-pyrrolo[3,2-c]pyridin-4-one compoundsBAYER AG·Filed 2020·Application pending·0 cites
- 2053US9902727B2Aminoalcohol substituted 2,3-dihydroimidazo[1,2-C]quinazoline derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesisBAYER IP GMBH·Filed 2014·Granted Feb 27, 2018·0 cites·15 claims
- 2147US2011250135A1Piperazine Derivatives for Binding and Imaging Amyloid Plaques and Their UseBAYER SCHERING PHARMA AG·Filed 2009·Application pending·0 cites
- 2246US6903126B21-Aryl-2-N-, S- or O-substituted benzimidazole derivatives, their use for the production of pharmaceutical agents as well as pharmaceutical preparations that contain these derivativesSCHERING AG·Filed 2002·Granted Jun 7, 2005·0 cites·14 claims
- 2346US2024307362A14H-PYRROLO[3,2-c]PYRIDIN-4-ONE COMPOUNDSBAYER AG·Filed 2020·Application pending·0 cites
- 2445US2017275268A1Heteroaryl substituted indazolesBayer Pharma AG·Filed 2017·Application pending·0 cites
- 2544US2016145267A1Heteroaryl substituted pyrazolesBayer Pharma AG·Filed 2014·Application pending·0 cites
- 2644US2016168130A1Heteroaryl substituted pyrazolesBayer Pharma AG·Filed 2014·Application pending·0 cites
- 2743US2021253598A1Aryl annulated macrocyclic indole derivativesBAYER AG·Filed 2018·Application pending·0 cites
- 2842US10130633B2CompoundsBayer Pharma AG·Filed 2014·Granted Nov 20, 2018·0 cites·17 claims
- 2942US2016052898A1Novel compoundsBayer Pharma AG·Filed 2014·Application pending·0 cites
- 3042US2016151370A1Substituted BenzylpyrazolesBayer Pharma AG·Filed 2014·Application pending·0 cites
- 3138US2016129011A1Bicyclo 2,3-benzodiazepines and spirocyclically substituted 2,3-benzodiazepinesBayer Pharma AG·Filed 2014·Application pending·0 cites
- 3236US9730943B2Alkoxy-substituted 2,3-dihydroimidazo[1,2-C]quinazolinesSCOTT WILLIAM JOHNSTON·Filed 2011·Granted Aug 15, 2017·0 cites·5 claims
- 3336US2012237446A1Compounds for binding and imaging amyloid plaques and their useROEHN ULRIKE·Filed 2012·Application pending·0 cites
- 3435US2017275269A1Benzyl substituted indazoles as bub1 kinase inhibitorsBayer Pharma AG·Filed 2015·Application pending·0 cites
- 3535US2017275270A1Benzyl substituted indazolesBayer Pharma AG·Filed 2015·Application pending·0 cites
- 3635US2017305882A1Benzyl substituted indazoles as bub1 kinase inhibitorsBayer Pharma AG·Filed 2015·Application pending·0 cites
- 3733US2018044306A11,3,4-thiadiazol-2-yl-benzamide derivatives as inhibitors of the wnt signalling pathwayBayer Pharma AG·Filed 2016·Application pending·0 cites
- 3833US2018042931A1N-phenyl-(morpholin-4-yl or piperazinyl)acetamide derivatives and their use as inhibitors of the wnt signalling pathwaysBayer Pharma AG·Filed 2016·Application pending·0 cites
- 3933US2018028507A13-carbamoylphenyl-4-carboxamide and isophtalamide derivatives as inhibitors of the wnt signalling pathwayBayer Pharma AG·Filed 2016·Application pending·0 cites
- 4031US2017107212A1Novel compoundsBayer Pharma AG·Filed 2015·Application pending·0 cites
- 4131US2017114070A1Inhibitors of the wnt signalling pathwaysBayer Pharma AG·Filed 2015·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →